Table 1

Baseline characteristics of entire cohort, according to the presence or absence of renal impairment (eGFR<60 mL/min)

OverallBaseline eGFR
<60 mL/min/1.73 m2
p Value
(n=897)No (n=639)Yes (n=258)
Age (years)71.8±9.069.8±8.976.7±7.3<0.001
Women (%)41.836.953.9<0.001
Permanent AF (%)43.140.749.20.021
Body mass index (kg/m2)27.9±4.628.1±4.627.7±4.50.300
Ankle-Brachial Index ≤0.90 (%)21.616.634.1<0.001
CHA2DS2-VASc score3.0 (2.0–4.0)3.0 (2.0–4.0)4.0 (3.0–5.0)<0.001
Arterial hypertension (%)86.385.488.40.284
Diabetes mellitus (%)24.122.727.50.075
History of MI/CHD (%)18.416.722.50.029
Heart failure (%)19.016.425.20.003
History of stroke/TIA (%)11.311.111.60.816
ACE inhibitor/ARBs (%)72.871.476.40.074
β blockers (%)48.647.152.30.090
Calcium channel antagonists (%)27.226.030.20.195
Statins (%)44.443.346.90.336
Antiplatelets (%)19.620.517.40.309
  • ACE, angiotensin converting enzyme; AF, atrial fibrillation; ARBs, angiotensin receptor blockers; CHD, coronary heart disease; eGFR, estimated glomerular filtration rate; MI, myocardial infarction; TIA, transient ischaemic attack.